PpPfs25/ISA51 and ScPvs25/ISA51 Vaccines for Malaria

PHASE1CompletedINTERVENTIONAL
0
Timeline

Start Date

March 7, 2005

Study Completion Date

June 17, 2008

Conditions
Plasmodium FalciparumPlasmodium Vivax Malaria
Interventions
DRUG

PpPfs25/ISA51 & ScPvs25/ISA51

Trial Locations (2)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

21205

Johns Hopkins School of Public Health, Baltimore

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00295581 - PpPfs25/ISA51 and ScPvs25/ISA51 Vaccines for Malaria | Biotech Hunter | Biotech Hunter